Quick protocol for depression with intravenous ketamine.
Zenodo (CERN European Organization for Nuclear Research) July 9, 2026 DOI: 10.5281/zenodo.21284219 via OpenAlex
Summary
Intravenous ketamine is an effective treatment for depression that does not respond to other therapies, but it requires close monitoring because of possible side effects and inconsistent results. Guidelines support its use, though efficacy varies among patients.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Population | Patients with treatment-resistant depression |
| Topics | Ketamine |
| Keywords | Protocol science Depression economics Intravenous drug Anesthesia |
| Key finding | Intravenous ketamine is supported by guidelines for treatment-resistant depression but requires careful monitoring due to variable efficacy and side effects. |
Abstract
Intravenous ketamine is used for treatment-resistant depression, with structured guidelines supporting its use, but requires careful patient monitoring due to potential side effects and variable efficacy.